BioCardia, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Sunnyvale, CA
BCDA chart
What traders are saying about $BCDA
Latest postsBioCardia, Inc. news
- BioCardia Inc (6JU0.MU) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- BioCardia (NASDAQ:BCDA) Penny Stock Up 6% Pre-Market on an FDA Procedural Step
kalkine.ca ·
- BioCardia, Inc. Estimates – NASDAQ:BCDA
TradingView ·
- BioCardia Announces FDA Acceptance of De Novo Pre-Submission Package for Helix™ Catheter Marketing Clearance FDA Substantive Review and Meeting Expected this Quarter
Yahoo Finance ·
- BioCardia Presents CardiAMP HF II Trial Design at Heart Failure Society of America Annual Scientific Meeting
Yahoo Finance ·
- BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter
Yahoo Finance ·
- BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission
Yahoo Finance ·
- BioCardia to Present CardiAMP Regulatory and Corporate Progress at H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance ·
- BioCardia Announces FDA Confirms Helix Transendocardial Delivery Catheter Meeting Minutes Supporting Follow-On De Novo Pre-Submission for Approval
Yahoo Finance ·
- BioCardia (BCDA) Q2 2026 Earnings Call Transcript
fool.com ·
- BioCardia Inc (BCDA) (Q2 2026) Earnings Call Highlights: Regulatory Wins in Japan and US ...
Yahoo Finance ·
- BioCardia, Inc. Q2 2026 Earnings Call Summary
app.moby.co ·
BioCardia, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$8.2M | -$7.9M | -$11.6M | -$11.9M |
| Total assets (year end) | $3.4M | $3.7M | $3.0M | $9.8M |
| Cash and equivalents (year end) | $2.5M | $2.4M | $1.1M | $7.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About BioCardia, Inc.
- Ticker
- BCDA (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Sunnyvale, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 925741
- Former names
- Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC
Frequently asked questions
What exchange is BioCardia, Inc. listed on?
BioCardia, Inc. trades on the Nasdaq under the ticker symbol BCDA.
What industry is BioCardia, Inc. in?
BioCardia, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is BioCardia, Inc. headquartered?
BioCardia, Inc.'s business address on file with the SEC is in Sunnyvale, CA.
When does BioCardia, Inc.'s fiscal year end?
BioCardia, Inc.'s fiscal year ends on December 31.
How much revenue did BioCardia, Inc. report?
BioCardia, Inc. reported $479,000 in revenue for calendar year 2017, according to its SEC filings.